Most Recent
Mayne Pharma cannot access invoices from Cosette’s solicitors at Corrs Chambers Westgarth, with a judge saying he was not hopeful that they would help to resolve a costs fight related to litigation over their collapsed $672 million merger.
A judge has refused to disqualify himself from case managing Mayne Pharma's latest dispute with US drug maker Cosette over the collapse of their $672 million merger agreement, calling the bid “plainly premature”.
A judge has approved orders bringing the receivership of Banksia Securities to an end, with the special receiver opting to not pursue $650,000 in costs against Victorian debenture holders who dropped their case alleging breaches to the scandal-ridden class action.
Mayne Pharma has launched a bid for a $13.6 million gross sum costs order against US drug maker Cosette, after winning one of numerous legal challenges over the termination of a $672 million merger agreement.
A judge has given the administrator for billionaire Sanjeev Gupta's Tahmoor Coal two more weeks to prove that creditors would be better off under a sale process than a liquidation.
An appeals court has thrown out mining billionaire and AMCI co-founder Hans Mende's challenge to a ruling that found his decision to sack the group's Australian managing director was invalid.
A judge has dismissed a bid by two Liberty Steel companies to stay a case brought in NSW by administrators for collapsed supply chain finance company Greensill while a related case in the UK proceeds.
Banksia Securities investors who agreed to drop their case alleging breaches linked to a scandal-ridden class action have been hit with costs, with a judge saying the case was “plainly” not for the benefit of all group members.
Two Liberty Steel companies want a case brought in NSW by administrators for collapsed supply chain finance company Greensill to be put on hold while a related case in the UK is on foot.
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.